Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVAC
1976
DELISTED
Intevac Inc
IVAC
| $2.32M | ﹤0.01% |
567,777
-1,868
| -0.3% | -$11.2K |
|
|
CDTX
1977
DELISTED
Cidara Therapeutics
CDTX
| $2.32M | ﹤0.01% |
46,780
+6,997
| +18% | +$419K |
|
1978
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $2.31M | ﹤0.01% |
25,900
+2,200
| +9% | +$195K |
|
|
GRA
1979
DELISTED
W.R. Grace & Co.
GRA
| $2.31M | ﹤0.01% |
65,000
-188,900
| -74% | -$10.8M |
|
|
RADA
1980
DELISTED
Rada Electronic Industries Ltd
RADA
| $2.31M | ﹤0.01% |
658,836
+264,712
| +67% | +$1.37M |
|
1981
Warner Bros
WBD
$67.1B
| $2.3M | ﹤0.01% |
118,400
-193,950
| -62% | -$5.32M |
|
1982
Kadant
KAI
$3.98B
| $2.3M | ﹤0.01% |
30,800
-13,500
| -30% | -$1.28M |
|
1983
Apyx Medical
APYX
$173M
| $2.29M | ﹤0.01% |
637,595
+14,700
| +2% | +$98.7K |
|
1984
Werner Enterprises
WERN
$2.24B
| $2.29M | ﹤0.01% |
63,093
+17,430
| +38% | +$627K |
|
1985
CEMIG Preferred Shares
CIG
$6.06B
| $2.29M | ﹤0.01% |
2,636,393
-2,626,946
| -50% | -$4.05M |
|
1986
Cullen/Frost Bankers
CFR
$10.2B
| $2.27M | ﹤0.01% |
40,700
-11,600
| -22% | -$946K |
|
1987
StoneX
SNEX
$8.05B
| $2.27M | ﹤0.01% |
316,543
-73,047
| -19% | -$648K |
|
1988
Pure Cycle
PCYO
$261M
| $2.27M | ﹤0.01% |
203,200
+118,000
| +138% | +$1.43M |
|
|
SY
1989
So-Young International
SY
$209M
| $2.26M | ﹤0.01% |
+221,100
| New | +$2.7M |
|
1990
Freedom Holding
FRHC
$9.51B
| $2.26M | ﹤0.01% |
159,209
+63,353
| +66% | +$953K |
|
1991
BJ's Restaurants
BJRI
$1.48B
| $2.26M | ﹤0.01% |
162,529
+88,200
| +119% | +$2.83M |
|
1992
Brookfield Infrastructure Partners
BIP
$18B
| $2.25M | ﹤0.01% |
93,600
-267,936
| -74% | -$7.83M |
|
|
TGB
1993
Trekor Metals
TGB
$3.09B
| $2.25M | ﹤0.01% |
8,428,653
-550,504
| -6% | -$228K |
|
|
APTO
1994
DELISTED
Aptose Biosciences, Inc.
APTO
| $2.25M | ﹤0.01% |
849
+774
| +1,032% | +$2.31M |
|
|
BLDP
1995
Ballard Power Systems
BLDP
$775M
| $2.25M | ﹤0.01% |
+296,413
| New | +$2.88M |
|
1996
Rocky Mountain Chocolate Factory
RMCF
$7.93M
| $2.24M | ﹤0.01% |
467,291
-13,830
| -3% | -$107K |
|
1997
Ichor Holdings
ICHR
$2.48B
| $2.24M | ﹤0.01% |
+116,700
| New | +$3.53M |
|
1998
MakeMyTrip
MMYT
$5.63B
| $2.23M | ﹤0.01% |
186,853
+59,533
| +47% | +$1.29M |
|
|
CXO
1999
DELISTED
CONCHO RESOURCES INC.
CXO
| $2.23M | ﹤0.01% |
52,042
+10,542
| +25% | +$733K |
|
2000
SM Energy
SM
$7.01B
| $2.23M | ﹤0.01% |
+1,825,300
| New | +$12.9M |
|
Similar funds
Renaissance Technologies's Q1 2020 Portfolio in Review
As of Q1 2020, Renaissance Technologies held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Renaissance Technologies's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Renaissance Technologies added most to Baidu in Q1 2020, an estimated $462M increase.
- Renaissance Technologies's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Renaissance Technologies fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Renaissance Technologies's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Renaissance Technologies opened 573 new positions and closed 645 in Q1 2020.
- Renaissance Technologies's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.